Cost-cutting is a frequent task of today's packaging engineer. Pharmaceutical and medical device manufacturers are looking to reduce costs wherever they can, so engineers must balance new packaging development with savings-minded product life cycle management.
But how can packaging engineers possibly juggle this increasing workload? Companies must develop a portfolio management process for prioritizing all projects, advises Stephen Birtsas, a manager with global innovation management consultancy Kalypso.
Thanks to ICH Q8 on Pharmaceutical Development, considerations such as Quality by Design, Critical Quality Attributes, and Design Space have crept into day-to-day drug development and production, influencing several packaging decisions. In essence, these concepts have encouraged drug manufacturers to better understand drug stability, resulting in a closer examination of risks using science.
The U.S. Federal Trade Commission (FTC) does not plan to challenge Rx-360 on its audit-sharing programs in which pharmaceutical and biotechnology companies share supplier-audit information and expenses. According to Rx-360, this decision will enable the consortium to proceed with plans to implement its audit sharing programs.
Wyeth (Collegeville, PA) has announced the winners of its first-ever Global Recognition for Outstanding Wyeth Suppliers (GROWS) awards program. Recipients were selected by Wyeth for their outstanding performance during 2008 in six categories: Quality; Delivery; Customer Service; Technical Support; Continuous Improvement; and Supplier of the Year.
Suppliers to Wyeth’s major manufacturing sites in North America and Europe were evaluated by a selection committee made up of procurement, manufacturing and quality and compliance representatives from the company’s Technical Operations and Product Supply (TO&PS) network.